| Financial Year |
March 31 2023 |
| Monetary Funds |
324,596,764.11 |
| Held-for-trading Financial Assets |
23,140,862.54 |
| Notes Receivable |
-- |
| Accounts Receivable |
3,127,332,001.11 |
| Advances to Suppliers |
598,687,572.91 |
| Other Receivables |
505,306,803.81 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
76,853,099.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
9,111,616.71 |
| Total Current Assets |
4,785,603,467.36 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
81,261,481.02 |
| Investment Properties |
-- |
| Fixed Assetes |
26,835,666.21 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
44,474,216.65 |
| R&D expenses |
-- |
| Goodwill |
37,247,462.11 |
| Long-Term Deferred and Prepaid Expenses |
24,680,266.45 |
| Deferred Income Tax Assets |
91,152,726.38 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
670,137,341.35 |
| Total Assets |
5,455,740,808.71 |
| Short-Term Loans |
767,470,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
30,000,000.00 |
| Accounts Payable |
2,614,002,506.81 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
54,630,617.00 |
| Taxes Payable |
45,041,518.38 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
161,739,980.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
60,889,518.47 |
| Other Current Liabilities |
1,839,273.14 |
| Sub-Total of Current Liabilities |
3,766,267,966.74 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
139,536,936.32 |
| Total Liabilities |
3,905,804,903.06 |
| Paid-In Capital(Or Share Stock) |
253,336,552.00 |
| Capital Surplus |
940,332,749.52 |
| Surplus Reserve |
135,475,082.68 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
252,184,035.14 |
| Minority Stockholder's Interest |
-15,752,670.59 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,565,688,576.24 |
| Owner's Equity（Stockholder's Equity） |
1,549,935,905.65 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,455,740,808.71 |
